Ultragenyx Pharmaceutical (RARE) traded up 2.69 % during a 24 hours period ending at 06:58 AM Central Europe on Friday 30th. One Ultragenyx Pharmaceutical stock can currently be bought for about USD 16.78 on popular exchanges. Current supply of Ultragenyx Pharmaceutical stocks is 98.6 mn. Ultragenyx Pharmaceutical has a current market capitalization of USD 1.7 bn and approximately USD 39.9 mn worth of Ultragenyx Pharmaceutical was traded on exchanges in the last 24 hours. Since last month end, Ultragenyx Pharmaceutical has traded 12.27 % up. Simple moving average of last 200 days is at USD 22.97. The highest price of past 52 weeks was recorded at USD 39.89 on 12/08/2025. 52 weeks low was at USD 12.73 on 09/16/2026.
Here is how related stocks have performed in the past 24 hours:
Idt (IDT) traded up 0.17 % and now trades at USD 81.74. Current market capitalisation for Idt is USD 2 bn. Current price/earnings ratio for Idt is 23.57.
Zymeworks (ZYME) traded up 0.17 % and now trades at USD 28.71. Zymeworks has a market capitalisation of USD 2 bn.
Vir Biotechnology (VIR) traded up 3.11 % and now trades at USD 11.75. Current market capitalisation for Vir Biotechnology is USD 2 bn.
Absci (ABSI) traded up 12.39 % and now trades at USD 12.1. Current market capitalisation for Absci is USD 2 bn.
Sarepta Therapeutics (SRPT) traded down -0.47 % and now trades at USD 19.23. Current market capitalisation for Sarepta Therapeutics is USD 2 bn.
About Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical Inc. is a biotechnology service provider based in Novato, United States. The company specializes in developing therapeutics and sialic acid for treating metabolic, body myopathy, glucuronidase, and rare genetic diseases.